Patient resource

Can ADHD medication be prescribed via telehealth in NC?

By Josephine W. Hazeley, MSN, PMHNP-BC
Board-certified psychiatric mental health nurse practitioner with a perinatal & postpartum focus — nearly two decades in psychiatric nursing, including research nursing on the trial behind the first FDA-approved postpartum-depression therapy. About your clinician

Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on July 4, 2026 · Last updated July 4, 2026

Yes. Under a federal extension of the COVID-era telemedicine rules, ADHD medication — including stimulant medication — can currently be prescribed to a North Carolina patient via telehealth without a prior in-person visit, through December 31, 2026 (Federal Register). The permanent rule expected to replace that extension may change the requirements, and this page will be updated when it does.

Current as of July 4, 2026. Prescribing rules are federal, temporary, and subject to change — check the date on this line before relying on this page.

The question exists because the common ADHD stimulants — Adderall, Ritalin, and their relatives — are Schedule II controlled substances, the most tightly regulated category of prescribable medication (DEA drug scheduling). Federal law sets special conditions on prescribing them, and for telehealth those conditions have been in motion since 2020.

How did the current rules come about?

Federal law (the Ryan Haight Act) generally required a prescriber to conduct an in-person medical evaluation before prescribing a controlled substance based on a telehealth encounter. DEA and HHS suspended that requirement at the start of the COVID-19 public health emergency; telemedicine prescribing of controlled medications has been permitted under those flexibilities since March 2020 (Federal Register). The agencies have extended the flexibilities repeatedly rather than let them lapse while permanent rules are written — the rule in force now is the fourth temporary extension.

What does the extension actually allow?

Through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances via telemedicine to a patient they have never examined in person, provided the rule’s conditions are met — including that the prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice (Federal Register).

In plain words: the extension changed where the clinical encounter can happen, not the standard it has to meet. The prescription still has to come out of a real evaluation and real clinical judgment.

What might change after 2026?

DEA has proposed a permanent framework to replace the extensions. Announced January 16, 2025, the proposed “special registration” rules would require practitioners to register specifically for telemedicine prescribing: a general registration would cover Schedule III–V medications, while a separate, more restricted Advanced Telemedicine Prescribing Registration would cover Schedule II medications and be limited to certain board-certified specialists. The same package proposes a national prescription drug monitoring program (DEA announcement).

Those rules are proposed, not final. The final version could keep, loosen, or tighten the Schedule II restrictions, and it is expected before the current extension expires on December 31, 2026. Until a final rule takes effect, the extension above is the law that applies.

What does this mean for you in North Carolina?

Practically: a telehealth psychiatric evaluation today can lead to stimulant treatment when that is the clinically appropriate outcome — no in-person visit first, no drive to a clinic. “Clinically appropriate” is the load-bearing phrase. Prescribing follows a diagnosis, and at Mindful Counseling & Wellness a diagnosis follows a thorough adult ADHD evaluation — the evaluation is the service, and a prescription is one possible outcome of it, never a guaranteed one.

Controlled-substance prescribing also carries obligations beyond the visit itself. At this practice that includes verifying your identity, reviewing North Carolina’s prescription-monitoring data before prescribing, and scheduled follow-up visits to monitor response and side effects. Those steps are part of prescribing these medications safely, and they apply by video exactly as they would in an office — how telehealth psychiatry works in North Carolina covers the wider logistics.

One commitment, since rules like this move: this page sits on a quarterly review cycle tied to the December 31, 2026 expiry, and the “current as of” line near the top reflects the last check.

If you want an evaluation rather than a rules briefing, get started — new patients are typically seen within 1–3 business days.